Skip to main content

Table 2 Example choice question from study

From: Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study

Pharmaceutical A

 

Pharmaceutical B

Average (5 years)

Survival

Low (1 year)

High improvement in QoL (50%)

Quality of life

Low improvement QoL (15%)

No

Alternative treatment

Yes

5 years

Age group

18 to 60 years

High: 500 million IRR (11,900 US dollar)

Cost to government

High: 500 million IRR (11,900 US dollar)

Severe: low longevity (up to 3 month); low QoL (30%)

Disease severity

Mild: high longevity (15 years), moderate QoL (60%)

Domestic production

Drug manufacturer country

Imported

Which pharmaceutical do you prefer to be subsidized?

Pharmaceutical A Pharmaceutical B